How We're Keeping You Safe | What Patients & Families Need to Know
The media relations staff in the Marketing and Communications Department at Cincinnati Children's is committed to providing the news media and families with the latest news and highlights about Cincinnati Children's and its efforts to improve children's health.
Following two decades of research on a group of rare diseases called hypereosinophilic syndrome, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) for use in the treatment of patients with hypereosinophilic syndrome.
Cincinnati Children’s announces the naming of The Cure Starts Now Foundation Brain Tumor Center as part of a multimillion-dollar donation to fund pediatric brain cancer research.
Scientists use human intestinal organoids grown from stem cells to discover how our bodies control the absorption of nutrients from the food we eat.
Study reports neurons inside our brains express a protein that can detect a specific wavelength of light from the sun. Those neurons send signals that influence a number of our body functions—including our metabolism.
Acute flaccid myelitis (AFM) is a rare, but serious, illness that affects the nervous system, mostly in children between the ages of 3 to 10-years-old.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462
© 1999-2020 Cincinnati Children's Hospital Medical Center. All rights reserved.